Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis – PR Newswire

Written by

admin

in

  1. Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis  PR Newswire
  2. Novo Nordisk’s obesity drug Wegovy cleared to treat MASH  statnews.com
  3. Novo Nordisk announces FDA approves additional indication of Wegovy  TipRanks
  4. Novo Nordisk’s Wegovy gets accelerated U.S. approval for liver disease  The Globe and Mail
  5. Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH  Yahoo Finance

Continue Reading

More posts